By analyzing MRI scans with greater accuracy, Alzevita provides clear and measurable insights into brain health, helping doctors diagnose the disease earlier and track its progression.
Provides precise hippocampal segmentation and volume analysis to support early Alzheimer’s detection
Reduces manual effort with automated analysis, delivering real-time results for quick decision-making
Easily integrates into clinical workflows, enhancing efficiency and supporting better patient care
Alzheimer’s disease affects memory, thinking, and behaviour, gradually impacting a person’s daily life. Early detection is key to managing the condition and planning the right care.
Alzevita focuses on analyzing the hippocampus, the part of the brain linked to memory and one of the first areas affected by Alzheimer’s. By providing precise hippocampal volume measurements, Alzevita helps doctors identify changes early, monitor disease progression, and make more informed treatment decisions.
Alzevita is helping clinicians detect Alzheimer’s earlier, track its progression more effectively, and improve patient outcomes through data-driven care.
Alzevita is precise in Early Alzheimer's Detection, Empowering healthcare professionals with accurate brain analysis, real-time monitoring, and secure cloud-based access for seamless diagnosis and personalized care.
We are looking for licensing and distribution partners to help expand access to Alzevita worldwide